Concord Biotech informs about board meeting

06 Feb 2026 Evaluate
Concord Biotech has informed that the meeting of the Board of Directors of the Company will be held on Wednesday, February 11, 2026 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Third quarter and nine month ended December 31, 2025 along with limited review report to be issued by the Statutory Auditors and to consider other business matters, if any. Further, in continuation of its earlier letter dated December 26, 2025 under subject ‘Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and Report trading by Designated Persons and their immediate relative, the trading window for dealing in the securities of the Company shall remain closed up to 48 hours after the declaration of the Financial Results of the Company for the Third quarter and nine month ended December 31, 2025.

The above information is a part of company’s filings submitted to BSE. 

Concord Biotech Share Price

1339.30 171.70 (14.71%)
06-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.70
Dr. Reddys Lab 1241.15
Cipla 1330.80
Zydus Lifesciences 887.85
Lupin 2168.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×